Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 4/20 | 0.55 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.43 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28434491 | 0.83 | CHRNA7 (0.46) | HSD11B1ALDH1A1 | |
| SCHEMBL5106732 | 0.79 | HSD11B1 (0.59) | HSD11B1ROCK2DDB1CRBNNPC1 | |
| SCHEMBL952662 | 0.76 | FAAH (0.32) | — | |
| SCHEMBL28942364 | 0.76 | HSD11B1 (0.59) | HSD11B1ROCK2DDB1CRBNNPC1 | |
| SCHEMBL5088875 | 0.76 | HSD11B1 (0.59) | HSD11B1ROCK2DDB1CRBNNPC1 | |
| SCHEMBL6733710 | 0.74 | HSD11B1 (0.57) | HSD11B1ROCK2DDB1CRBNALDH1A1 | |
| Hydrochloric Acid SCHEMBL5236156 | 0.74 | HSD11B1 (0.57) | HSD11B1ROCK2DDB1CRBNNPC1 | |
| SCHEMBL6484479 | 0.74 | L3MBTL1 (0.40) | ALDH1A1KMT2ASIGMAR1 | |
| SCHEMBL6654051 | 0.73 | HSD11B1 (0.56) | HSD11B1ROCK2DDB1CRBNNPC1 | |
| SCHEMBL6654054 | 0.73 | HSD11B1 (0.56) | HSD11B1ROCK2DDB1CRBNNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0434362-B1 | Graft copolymer, solution containing the graft copolymer, and method of treating contact lens with the solution | TOMEI SANGYO KK (JP) | 1995-03-22 | — | — | EP | claimed |
| EP-0433046-B1 | Polymer-type polymerization initiator | TOMEI SANGYO KK (JP) | 1994-08-10 | — | — | EP | claimed |
| US-5206298-A | GRAFT COPOLYMER, SOLUTION CONTAINING THE GRAFT COPOLYMER FOR TREATING CONTACT LENS, AND METHOD OF TREATING CONTACT LENS WITH THE SOLUTION AND MAKING HYDROPHILIC LENS SURFACE | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1993-04-27 | — | — | US | claimed |
| US-5134213-A | N-Vinyllactam-Monoperoxyfumarate Terpolymer | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1992-07-28 | — | — | US | claimed |
| US-5082912-A | For graft polymerization, surfactants | TOMEI SANGYO KABUSHIKI KAISHA (JP) | 1992-01-21 | — | — | US | claimed |
| EP-0434362-A1 | Graft copolymer, solution containing the graft copolymer, and method of treating contact lens with the solution | Tomei Sangyo Kabushiki Kaisha (JP) | 1991-06-26 | — | — | EP | claimed |
| EP-0433046-A2 | Polymer-type polymerization initiator | Tomei Sangyo Kabushiki Kaisha (JP) | 1991-06-19 | — | — | EP | claimed |
| US-4772359-A | POLY-N-VINYLAMIDE AS DRAINAGE AID | BASF AKTIENGESELLSCHAFT (DE) | 1988-09-20 | — | — | US | claimed |
| EP-0249891-A1 | Process for producing paper and cardboard | BASF Aktiengesellschaft (DE) | 1987-12-23 | — | — | EP | claimed |
| US-12252632-B2 | Chemical-mechanical polishing composition, rinse composition, chemical- mechanical polishing method, and rinsing method | ENTEGRIS, INC. (US) | 2025-03-18 | — | — | US | disclosed |
| US-20250032510-A1 | AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION | IMMEDICA PHARMA US INC. | 2025-01-30 | — | — | US | disclosed |
| US-20230390305-A1 | AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION | MARINUS PHARMACEUTICALS, INC. | 2023-12-07 | — | — | US | disclosed |
| WO-2023060067-A1 | AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION | MARINUS PHARMACEUTICALS, INC. (US) | 2023-04-13 | — | — | WO | disclosed |
| US-20220372329-A1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION, RINSE COMPOSITION, CHEMICAL-MECHANICAL POLISHING METHOD, AND RINSING METHOD | ENTEGRIS, INC. | 2022-11-24 | — | — | US | disclosed |
| US-4711830-A | Image recording material comprising photosensitive layer and recording layer on electroconductive base | CANON KABUSHIKI KAISHA (JP) | 1987-12-08 | — | — | US | disclosed |
| EP-0233039-A2 | Image forming method | CANON KABUSHIKI KAISHA (JP) | 1987-08-19 | — | — | EP | disclosed |
| EP-0091039-B1 | ANTI-FOULING AGENT | Nitto Kasei Co., Ltd. (JP) | 1986-10-01 | — | — | EP | disclosed |
| EP-0191645-A2 | Recording medium and recording method by use thereof | CANON KABUSHIKI KAISHA (JP) | 1986-08-20 | — | — | EP | disclosed |
| US-4526932-A | Copolymer containing N-coordinated triorganotin compound | NITTO KASEI CO., LTD. (JP) | 1985-07-02 | — | — | US | disclosed |
| EP-0091039-A2 | Anti-fouling agent | Nitto Kasei Co., Ltd. (JP) | 1983-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032510-A1 | AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION | PYGB, GYS2, CYP21A2 | HSD11B1 35/4885ROCK2 1102/4885DDB1 3493/4885 |
| US-20230390305-A1 | AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION | PYGB, GYS2, CYP21A2 | HSD11B1 35/4885ROCK2 1102/4885DDB1 3493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.